Brief: Supernus Pharmaceuticals Q1 Product Sales USD 150.8 Million
05/05/2026 21:05
May 05 (Reuters) - Supernus Pharmaceuticals Q1 operating earnings USD -8.332 million. Q1 adjusted revenue USD 178.4 million Q1 adjusted operating earnings USD 28.7 million vs. IBES estimate USD 8.7 million
Recent news on Supernus Pharmaceuticals
See all newsHuron Consulting poised to hit fresh record ahead of S&P SmallCap addition
Brief: S&P Dow Jones Indices Msg Rangers And Huron Consulting Group Set To Join S&P Smallcap 600
Brief: Supernus Pharmaceuticals Says FDA Grants Seven Years Orphan-Drug Exclusivity For Onapgo
Supernus Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE -Micron Technology, Ares Management, Boeing